# Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure

> **NCT04733105** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 1022 (actual)

## Conditions studied

- Acute Respiratory Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04733105
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-20
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-10-30
- **Target enrollment:** 1022 (ACTUAL)
- **Last updated:** 2021-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04733105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04733105, "Pronostic Value of Type I ANTi-Interferon Antibodies in Patients With COVID-19 Acute Respiratory Failure". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04733105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*